234 / 400
MONDAY
TUESDAY
WEDNESDAY
THURSDAY
SCIENTIFIC PROGRAMME
226
002
Sexual violations a particular problem among
female refugees
Marianne C. Kastrup, Denmark
003
Health care services for female refugees in
Australia
Kym Jenkins, Australia
004
Results of a representative study: expectations
of female refugees
Meryam Schouler-Ocak, Germany
S-364
Symposium
10:00– 11:30
|
Hall Helsinki 1
TOPIC 6:
Eating disorders, sleep disorders and other
disorders of this category
New developments in the treatment of eating
disorders over the life span
Chairs:
Beate Herpertz-Dahlmann, Germany
Ulrike Schmidt, United Kingdom
001
Treatment setting matters – advantages and
disadvantages of inpatient, day patient and home
treatment in young patients with AN
Beate Herpertz-Dahlmann, Germany
002
Repetitive transcranial magnetic stimulation:
new hope for patients with severe and enduring
anorexia nervosa?
Ulrike Schmidt, United Kingdom
003
Eating disorders and impulse related disorders:
shared vulnerabilities and management strategies
Fernando Fernández-Aranda, Spain
Susana Jimenez-Murcia
004
Attention deficit hyperactivity disorder, binge
eating disorder and obesity
Martina de Zwaan, Germany
S-365
Symposium
10:00– 11:30
|
Hall Paris 2
TOPIC 3:
Psychotic disorders
Exercise interventions in schizophrenia – promoting
recovery and disentangling underlying pathophys-
iology
Chairs:
Hilleke Hulshoff Pol, The Netherlands
Berend Malchow, Germany
001
Effects of early life physical activity patterns on
psychosis risk
Elina Sormunen, Turkey
002
Impaired cardiac response to incremental
exercise in patients with schizophrenia
Karl-Jürgen Bär, Germany
003
Feasibility and efficacy of aerobic endurance
training interventions in patients with schizophrenia
Berend Malchow, Germany
004
Changes in brain connectivity after endurance
training in patients with schizophrenia
Hilleke Hulshoff Pol, The Netherlands
S-366
Symposium
10:00– 11:30
|
Hall New York 1
TOPIC 3:
Psychotic disorders
The Soteria paradigm as an approach to reduce
doses of neuroleptic treatment
Chairs:
Martin Voss, Germany
Jürgen Gallinat, Germany
001
Why we need to search for new strategies to
reduce doses of neuroleptic treatment
Volkmar Aderhold, Germany
002
Introduction to the Soteria paradigm
Holger Hoffmann, Switzerland
003
Neurobiological mechanisms of the Soteria
paradigm
Jürgen Gallinat, Germany
004
Evidence for reduction of neuroleptic doses in
Soteria
Martin Voss, Germany
S-367
Symposium
10:00– 11:30
|
Hall New York 3
TOPIC 13:
Brain imaging, neurophysiology,
neuropsychology
Neuroimaging of schizophrenia: an update
›
WPA Section: Neuroimaging in Psychiatry
Chairs:
Silvana Galderisi, Italy
Lynn E. DeLisi, USA
001
Neuroimaging and psychopathological dimen-
sions in schizophrenia
Thomas Dierks, Switzerland
002
Neuroimaging and at-risk states
Stefan Borgwardt, Switzerland
003
Neuroimaging and longitudinal course
Geraldo Busatto, Brazil
004
Neuroimaging and antipsychotic treatment
Antonio Vita, Italy